Promising New PD Fluid
In a Phase 2 study, PD-protec® from Zytoprotec in Vienna, Austria, reduced the risk of peritonitis and of membrane failure. The new fluid was well-tolerated, with no adverse events. Once on the market, this fluid could improve PD outcomes and allow more people to stay longer on the therapy.
Read the full article » | Posted 07/14/2017
Related Articles
- Start-ups Around the Globe Focus on Portable PD Posted 02/19/2020
- A Cure for What Ails Kidneys? Posted 02/19/2020
- BioIntelliSense BioSticker is FDA-approved Posted 02/19/2020
- AWAK PD Attracts Funding Posted 01/09/2020
- Portable, Wearable Dialysis—from Russia With Love Posted 12/10/2019